The Global Viral Vector Manufacturing Market is estimated to grow at a CAGR of around 19.22% during the forecast period, i.e., 2024-30.
Global Viral Vector Manufacturing Market Driver:
Increased Burden of Genetic Disorders – During the past few years, there has been a significant surge in the number of genetic disorders globally. Among them, there has been a significant rise in the number of patients with hemophilia. For instance, the World Federation of Hemophilia (WFH) reported a global count of approximately 257,146 individuals diagnosed with the condition in 2022. Specifically, hemophilia A and B cases were recorded at 208,957 and 42,203, respectively. This surge in instances of hemophilia has resulted in an amplified demand for gene therapy for treatment purposes. Thus, this demand has consequently driven the need for viral vectors, essential for delivering gene therapy, thereby accelerating growth in the Viral Vector Manufacturing Market.
Additionally, the rising prevalence of other genetic blood disorders, notably sickle-cell disease and thalassemia, has further fueled market growth. According to the World Health Organization (WHO), approximately 5% of the global population carries trait genes for hemoglobin disorders, predominantly sickle-cell disease and thalassemia. Furthermore, increasing awareness and initiatives by government and non-governmental organizations aimed at educating the public about these genetic disorders and facilitating their diagnosis and treatment are contributing to the increased number of diagnosed patients who require therapies.
Download a free sample copy of the Report: https://www.marknteladvisors.com/query/request-sample/viral-vector-manufacturing-market.html
Key Market Reports Highlights
- Market Dimensions & Projections
- Pricing Evaluation
- Recent Strategic Moves by Companies
- Primary Stakeholders
- Import/Export Trend Analysis
- Competitive Landscape Assessment
- Emerging Opportunities
- Market Trends and Indicators
*Reports Delivery Format – Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Browse Full Report including (TOC+ List of Table and Figures): https://www.marknteladvisors.com/research-library/viral-vector-manufacturing-market.html
Global Viral Vector Manufacturing Market Segmentation:
The market report categorizes the market based on different segments and geographical analysis.
Study Timeline:
-Base Year: 2023
-Historical Period: 2019 to 2022
-Forecast Period: 2024 to 2030
- By Vector Type
- Adenoviral Vector- Market Size & Forecast 2019-2030, USD Million
- Adeno-Associated Viral Vector- Market Size & Forecast 2019-2030, USD Million
- Lentiviral Vector- Market Size & Forecast 2019-2030, USD Million
- Herpes Simplex Viral-Vector- Market Size & Forecast 2019-2030, USD Million
- Retroviral Vector- Market Size & Forecast 2019-2030, USD Million
- Others (CMV, HSV-1, Vaccina, etc.)- Market Size & Forecast 2019-2030, USD Million
- By Application
- Gene Therapy- Market Size & Forecast 2019-2030, USD Million
- Cell Therapy- Market Size & Forecast 2019-2030, USD Million
- Vaccines- Market Size & Forecast 2019-2030, USD Million
- Non-Replicating Viral Vector Vaccines- Market Size & Forecast 2019-2030, USD Million
- Replicating Viral Vector Vaccines- Market Size & Forecast 2019-2030, USD Million
- By Indication
- Genetic Disorders- Market Size & Forecast 2019-2030, USD Million
- Hemophilia- Market Size & Forecast 2019-2030, USD Million
- Sickle Cell Disease- Market Size & Forecast 2019-2030, USD Million
- Duchenne muscular dystrophy- Market Size & Forecast 2019-2030, USD Million
- Beta-Thalassemia- Market Size & Forecast 2019-2030, USD Million
- Spinal Muscular Atrophy (SMA)- Market Size & Forecast 2019-2030, USD Million
- Others (inherited retinal disorder, cerebral adrenoleukodystrophy (CALD, severe combined immunodeficiency due to adenosine deaminase deficiency)- Market Size & Forecast 2019-2030, USD Million
- Cancer- Market Size & Forecast 2019-2030, USD Million
- Bladder Cancer- Market Size & Forecast 2019-2030, USD Million
- Blood Cancer- Market Size & Forecast 2019-2030, USD Million
- Head & Neck Cancer- Market Size & Forecast 2019-2030, USD Million
- Infectious Diseases- Market Size & Forecast 2019-2030, USD Million
- COVID-19- Market Size & Forecast 2019-2030, USD Million
- Ebola Virus- Market Size & Forecast 2019-2030, USD Million
- Malaria- Market Size & Forecast 2019-2030, USD Million
- Genetic Disorders- Market Size & Forecast 2019-2030, USD Million
- By Scale of Operation
- Pre-Clinical- Market Size & Forecast 2019-2030, USD Million
- Clinical- Market Size & Forecast 2019-2030, USD Million
- Commercial- Market Size & Forecast 2019-2030, USD Million
- By End User
- Biotech Companies- Market Size & Forecast 2019-2030, USD Million
- Pharmaceutical Companies- Market Size & Forecast 2019-2030, USD Million
- Research Organizations- Market Size & Forecast 2019-2030, USD Million
- By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
Competitive Landscape
With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including – Oxford Biomedica PLC, Charles River Laboratories, FUJIFILM Corporation, Lonza, Merck KgaA, Catalent, Inc., AGC Biologics, Thermo Fisher Scientific Inc., Vector BioMed, Biovian Oy, ReiThera srl, Curia Global, Inc., Aurigene Pharmaceutical Services Ltd., Revvity, etc.
Have questions? Our consultant is ready to assist: https://www.marknteladvisors.com/query/talk-to-our-consultant/viral-vector-manufacturing-market.html
We follow a tried-and-tested research methodology that blends top-down and bottom-up approaches to deliver highly accurate market insights. Every report is powered by data triangulation, ensuring well-rounded and validated findings.
From smart sample selection and reliable data collection to in-depth analysis and precise forecasting, our process is designed to minimize error and maximize impact.
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Contact Us
MarkNtel Advisors
Email: sales@marknteladvisors.com
Website: www.marknteladvisors.com
Latest Press Release – https://www.marknteladvisors.com/press-release
